StemCells, Inc. Completes Dosing in Second Trial of HuCNS-SC(R) Neural Stem Cells
17 févr. 2011 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., Feb. 17, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that the fourth and final patient in its Phase I clinical trial in Pelizaeus-Merzbacher Disease (PMD)...
StemCells, Inc. to Present at BIO CEO & Investor Conference
08 févr. 2011 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., Feb. 8, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that President and CEO Martin McGlynn will present an update on the Company's programs and operations...
StemCells, Inc. Broadens Its SC Proven(R) Product Portfolio With Launch of Two Additional Human Cell Detection Antibodies
19 janv. 2011 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., Jan. 19, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today the launch of STEM24™ and STEM133™, two new antibody reagents that have utility for the...
StemCells, Inc. Closes $10 Million Common Stock Financing
11 janv. 2011 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., Jan. 11, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it has closed the sale of 10 million shares of common stock, at a fixed price of $1.00 per...
StemCells, Inc. Announces $10 Million Common Stock Financing
07 janv. 2011 09h02 HE
|
StemCells, Inc.
PALO ALTO, Calif., Jan. 7, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it has entered into an agreement to sell ten million shares of its common stock to selected...
StemCells, Inc. Receives Authorization to Conduct World's First Neural Stem Cell Trial in Spinal Cord Injury
07 déc. 2010 08h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., Dec. 7, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that is has received authorization from Swissmedic, the Swiss regulatory agency for therapeutic...
StemCells, Inc. Expands SC Proven(R) Product Portfolio With Launch of Proprietary Human Cell Detection Antibodies
06 déc. 2010 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., Dec. 6, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today the launch of STEM101™, STEM121™ and STEM123™, three new antibody reagents that...
Chardan Capital Markets Initiates Research Coverage of StemCells, Inc. With Buy Recommendation
19 nov. 2010 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., Nov. 19, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Chardan Capital Markets (Chardan) initiated independent equity research coverage on the Company...
StemCells, Inc. Files to Conduct Neural Stem Cell Trial in Chronic Spinal Cord Injury
15 nov. 2010 08h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., Nov. 15, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that is has filed an application with Swissmedic, the Swiss regulatory agency for therapeutic...
StemCells, Inc. Launches New Website
10 nov. 2010 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., Nov. 10, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today the launch of a completely redesigned corporate website with greatly expanded content and an enhanced...